Data / Form D filings / ACTUATE THERAPEUTICS, INC.
ACTUATE THERAPEUTICS, INC.: Form D filings
ACTUATE THERAPEUTICS, INC., a pharmaceuticals company in Fort Worth, TX, filed 13 Form D notices with the SEC between 2015 and 2025. The latest, on July 7, 2025, reports $4.7 million sold of a $9.3 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1751 RIVER RUN, SUITE 400, Fort Worth, TX, 76107
- Phone
- (817) 887-8455
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1652935
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2025 | New notice | $9,330,958 | $4,665,479 | $4,665,479 | 8 | Jun 27, 2025 | sec.gov |
| Apr 10, 2025 | New notice | $50,000,000 | $0 | $50,000,000 | 1 | Yet to occur | sec.gov |
| Mar 6, 2024 | New notice | $5,000,000 | $3,000,000 | $2,000,000 | 1 | Feb 20, 2024 | sec.gov |
| Dec 15, 2022 | Amendment | $50,000,000 | $19,336,491 | $30,663,509 | 95 | Sep 30, 2022 | sec.gov |
| Oct 19, 2022 | New notice | $50,000,000 | $11,170,000 | $38,830,000 | 30 | Sep 30, 2022 | sec.gov |
| Dec 10, 2020 | New notice | $50,000,000 | $14,482,301 | $35,517,699 | 14 | Nov 30, 2020 | sec.gov |
| Nov 14, 2019 | Amendment | $6,500,000 | $6,500,000 | 17 | Oct 1, 2019 | sec.gov | |
| Oct 15, 2019 | New notice | $6,500,000 | $3,942,540 | $2,557,460 | 14 | Oct 1, 2019 | sec.gov |
| May 13, 2019 | New notice | $23,952,152 | $21,886,833 | $2,065,319 | 21 | Apr 30, 2019 | sec.gov |
| Sep 12, 2018 | New notice | $4,025,000 | $4,025,000 | 18 | Aug 28, 2018 | sec.gov | |
| Mar 20, 2017 | New notice | $5,000,000 | $3,000,000 | $2,000,000 | 2 | Mar 17, 2017 | sec.gov |
| Feb 3, 2017 | New notice | $150,000 | $150,000 | 1 | Jan 18, 2017 | sec.gov | |
| Oct 8, 2015 | New notice | $500,000 | $410,000 | $90,000 | 4 | Sep 29, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Todd G.L. Thomson | Director | |
| Daniel Schmitt | Executive Officer, Director | |
| Paul Lytle | Executive Officer | |
| Roger G.L. Sawhney | Director | |
| Andrew G.L. Mazar | Executive Officer | |
| Amy G.L. Ronneberg | Director | |
| Daniel G.L. Zabrowski | Director | |
| Jason G.L. Keyes | Director | |
| Aaron G.L. Fletcher | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Jul 7, 2025 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ACTUATE THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.